Mr. Venkateswarlu Jasti, aged 70 years, is a Post Graduate in Pharmacy from Andhra University, Visakhapatnam, and also a Post Graduate in Pharmacy from St. John University, New York, specializing in Industrial Pharmacy. Having registered himself as a Registered Pharmacist, he successfully owned and operated a chain of six community pharmacies in the state of New York and New Jersey in USA from 1977 till 1989. He was the president elect of Essex County Pharmaceutical Society of New Jersey in 1988. He returned to India from USA and co-founded Suven Life Sciences Limited in 1989. Since then, he has been successfully managing the company providing the direction and leadership. Under his leadership, Suven Life Sciences Limited developed innovative business models like CRAMS (Contract Research and Manufacturing Services) and DDDSS (Drug Discovery & Development Support Services). Under his leadership, Suven Life Sciences Limited architected discovery programmes in the year 2004, leading to a pipeline of 13 molecules, with its first molecule SUVN-502 targeted against cognition in Alzheimer’s is undergoing proof of concept Phase 2 study in USA. All other molecules are in different phases of preclinical and clinical development programmes. He is the Chief architect for the formation of A.P. Chief Minister’s task force for Pharma during 2001 and responsible for the creation of Pharma City at Vishakhapatnam by Government of Andhra Pradesh and PHARMEXCIL (Pharmaceutical Export Promotion Council), head quartered at Hyderabad. He was Chairman for PHARMEXCIL till 2009. He is also Director on the Board of Suven Life Sciences Limited, FTCCI and Jasti Property and Equity Holdings Private Limited. He was President of Indian Pharmaceutical Association (IPA), and Chairman of Local Organizing Committee for the 52nd Indian Pharmaceutical Congress held at Hyderabad in 2001 and was President of Bulk Drug Manufacturers Association of India (BDMA) till September 2004.